Triple

T18750450
Position Surface form Disambiguated ID Type / Status
Subject Council Directive 93/42/EEC E458510 entity
Predicate amendedBy P1121 FINISHED
Object Directive 2001/104/EC NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Directive 2001/104/EC | Statement: [Council Directive 93/42/EEC, amendedBy, Directive 2001/104/EC]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Directive 2001/104/EC
Context triple: [Council Directive 93/42/EEC, amendedBy, Directive 2001/104/EC]
  • A. Directive 2004/24/EC
    Directive 2004/24/EC is a European Union law that created a simplified registration and regulatory framework for traditional herbal medicinal products across EU member states.
  • B. Directive 2004/23/EC
    Directive 2004/23/EC is a key European Union law that sets quality and safety standards for the donation, procurement, testing, processing, preservation, storage, and distribution of human tissues and cells for medical use.
  • C. Directive 2001/82/EC
    Directive 2001/82/EC is a key European Union law that sets out the rules for the authorization, supervision, and pharmacovigilance of veterinary medicinal products across EU member states.
  • D. Directive 2000/70/EC
    Directive 2000/70/EC is a European Union legislative act that updated and strengthened the regulatory framework for medical devices, particularly those incorporating stable derivatives of human blood or human plasma, within the scope of Council Directive 93/42/EEC.
  • E. Directive 2003/41/EC
    Directive 2003/41/EC was the original EU framework setting prudential and supervision rules for institutions for occupational retirement provision (IORPs) before being updated and replaced by the IORP II Directive.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Directive 2001/104/EC
Target entity description: Directive 2001/104/EC is a European Union legislative act that updates and refines the regulatory framework for medical devices originally established by Council Directive 93/42/EEC.
  • A. Directive 2004/24/EC
    Directive 2004/24/EC is a European Union law that created a simplified registration and regulatory framework for traditional herbal medicinal products across EU member states.
  • B. Directive 2004/23/EC
    Directive 2004/23/EC is a key European Union law that sets quality and safety standards for the donation, procurement, testing, processing, preservation, storage, and distribution of human tissues and cells for medical use.
  • C. Directive 2001/82/EC
    Directive 2001/82/EC is a key European Union law that sets out the rules for the authorization, supervision, and pharmacovigilance of veterinary medicinal products across EU member states.
  • D. Directive 2000/70/EC
    Directive 2000/70/EC is a European Union legislative act that updated and strengthened the regulatory framework for medical devices, particularly those incorporating stable derivatives of human blood or human plasma, within the scope of Council Directive 93/42/EEC.
  • E. Directive 2003/41/EC
    Directive 2003/41/EC was the original EU framework setting prudential and supervision rules for institutions for occupational retirement provision (IORPs) before being updated and replaced by the IORP II Directive.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8d394dc308190b6725073f5db324c completed April 10, 2026, 10:40 a.m.
NER Named-entity recognition batch_69e579ec71cc8190bb6d3fa6cca6dc8c completed April 20, 2026, 12:57 a.m.
Created at: April 10, 2026, 11:51 a.m.